Quoin Pharmaceuticals, Ltd.
QNRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,948 | -$3,696 | -$3,812 | -$2,311 |
| Dep. & Amort. | $25 | $25 | $25 | $25 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $182 | $321 | $360 | $326 |
| Change in WC | $86 | $255 | $900 | -$595 |
| Other Non-Cash | $1,429 | -$592 | -$67 | $319 |
| Operating Cash Flow | -$2,225 | -$3,686 | -$2,594 | -$2,237 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $2,943 | $0 |
| Other Inv. Act. | $2,538 | $1,683 | -$173 | -$3,178 |
| Investing Cash Flow | $2,538 | $1,683 | $2,770 | -$3,178 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$150 | -$150 | -$150 | -$150 |
| Stock Issued | $0 | $0 | $172 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $1 | $6,071 |
| Financing Cash Flow | -$150 | -$150 | $23 | $5,921 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $162 | -$2,154 | $199 | $507 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,668 | $3,822 | $3,623 | $3,117 |
| End Cash | $1,831 | $1,668 | $3,822 | $3,623 |
| Free Cash Flow | -$2,225 | -$3,686 | -$2,594 | -$2,237 |